Bloodstream Infection Testing Market
Description
Blood stream infection is a condition in which the blood is detected with bacterial, fungal, or any other infection. This condition normally occurs when the infection enters the blood stream of any part of body through wound, injection or during any surgical procedures. This infection is also considered as blood poisoning, bacteremia, septicemia, or sepsis. Self-diagnosis of blood stream infections is difficult, owing to its common symptoms (such as chills, fever, diarrhea, vomiting, and others), thereby testing is mandatory for detection of infections in blood.
Market Dynamics
Increasing prevalence of infections such as abdominal infections, dental infections, kidney and urinary infection, and chronic diseases drives the market growth. According to the World Health Organization (WHO), in 2016, over 30 million people are affected by sepsis worldwide, annually, leading to 6 million deaths. Moreover, increasing R&D investments related to bloodstream infection testing is also expected to boost the market growth. Moreover, high incidences of burns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer along with growing awareness about hygiene is also expected to boost the global bloodstream infection testing market growth. According to World Health Organization, at the end of 2017, approximately 36.9 million people living with HIV and 1.8 million people becoming newly ininfected in 2017 globally. However, the high diagnostic costs and insufficiency medical reimbursement may hinder the market growth.
Key features of the study
Market Dynamics
Increasing prevalence of infections such as abdominal infections, dental infections, kidney and urinary infection, and chronic diseases drives the market growth. According to the World Health Organization (WHO), in 2016, over 30 million people are affected by sepsis worldwide, annually, leading to 6 million deaths. Moreover, increasing R&D investments related to bloodstream infection testing is also expected to boost the market growth. Moreover, high incidences of burns/wounds cases, HIV, pneumonia, pyelonephritis, and cancer along with growing awareness about hygiene is also expected to boost the global bloodstream infection testing market growth. According to World Health Organization, at the end of 2017, approximately 36.9 million people living with HIV and 1.8 million people becoming newly ininfected in 2017 globally. However, the high diagnostic costs and insufficiency medical reimbursement may hinder the market growth.
Key features of the study
- This report provides in-depth analysis of the bloodstream infection testing market and provides market size (USD Mn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global bloodstream infection testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
- Key companies covered as a part of this study include, BioMérieux SA, Becton, Dickinson and Company, AB Sciex, IRIDICA, Abbot Laboratories, Cepheid Inc., C. R. Bard, Inc., F. Hoffmann-La Roche AG, Nanoshpere, Dade Behring, AdvanDX, Siemens Healthcare.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global bloodstream infection testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bloodstream infection testing market
- Product Type Insights (Revenue, USD Mn, 2026 - 2033)
- Instruments
- Reagents & Consumables
- Others
- Technology Insights (Revenue, USD Mn, 2026 - 2033)
- Conventional Testing
- Non-Conventional Testing
- Test Type Insights (Revenue, USD Mn, 2026 - 2033)
- Conventional Blood Culture Tests
- PCR Method
- Nucleic Acid Testing
- Mass Spectroscopy
- Point-Of-Care Testing
- End User Insights (Revenue, USD Mn, 2026 - 2033)
- Hospitals
- Independent Diagnostics Centers
- Others
- Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
- Key Players Insights
- BioMérieux SA
- Becton
- Dickinson and Company
- AB Sciex
- IRIDICA
- Abbot Laboratories
- Cepheid Inc.
- C. R. Bard, Inc.
- F. Hoffmann-La Roche AG
- Nanoshpere
- Dade Behring
- AdvanDX
- Siemens Healthcare
Table of Contents
153 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Bloodstream Infection Testing Market, By Product Type
- Global Bloodstream Infection Testing Market, By Technology
- Global Bloodstream Infection Testing Market, By Test Type
- Global Bloodstream Infection Testing Market, By End User
- Global Bloodstream Infection Testing Market, By Region
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend
- 4. Global Bloodstream Infection Testing Market, By Product Type, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Reagents & Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- 5. Global Bloodstream Infection Testing Market, By Technology, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Conventional Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Non-Conventional Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- 6. Global Bloodstream Infection Testing Market, By Test Type, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Conventional Blood Culture Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- PCR Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Nucleic Acid Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Mass Spectroscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Point-Of-Care Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- 7. Global Bloodstream Infection Testing Market, By End User, 2026-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Independent Diagnostics Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
- 8. Global Bloodstream Infection Testing Market, By Region, 2026 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
- 9. Competitive Landscape
- BioMérieux SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AB Sciex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IRIDICA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbot Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cepheid Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- C. R. Bard, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- F. Hoffmann-La Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nanoshpere
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dade Behring
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AdvanDX
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- 11. References and Research Methodology
- References
- Research Methodology
- About us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.